Why Axsome Therapeutics Inc (NASDAQ:AXSM) Stock climbed 18.37% in Last Three Months?
Needham raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock to “a Buy”. The rating was released on July 22, 2024, according to finviz. We previously noted in another research note published on April 29, 2024 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight with a price target […]
What’s best: jumping in or staying out? Axsome Therapeutics Inc (AXSM) Stock
Needham raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock to “a Buy”. The rating was released on July 22, 2024, according to finviz. We previously noted in another research note published on April 29, 2024 by Morgan Stanley that upgraded the stock from an Equal-weight to an Overweight with a price target […]
What do you think? Take A Moment To Read: Axsome Therapeutics Inc (AXSM) Stock
Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]
Stay away from Axsome Therapeutics Inc (AXSM) Stock or get into it
Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]
Why Axsome Therapeutics Inc (NASDAQ:AXSM) Stock rose 11.27% in Last Six Months?
Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]
Axsome Therapeutics Inc (AXSM) Stock Is Looking Attractive
Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]
Is Axsome Therapeutics Inc (AXSM) Stock a good investment?
Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]
